Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Nippon India Pharma Fund(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited13.678065563491044.5903
Domestic EquitiesDivi's Laboratories Limited9.32011298808711.7793
Domestic EquitiesLupin Limited7.72663098126590.0846
Domestic EquitiesCipla Limited5.89763200000450.4000
Domestic EquitiesDr. Reddy's Laboratories Limited5.35393662170408.8813
Domestic EquitiesApollo Hospitals Enterprise Limited5.1419648795392.6897
Domestic EquitiesAbbott India Limited3.820295985291.7526
Domestic EquitiesVijaya Diagnostic Centre Limited3.40932843231260.3689
Domestic EquitiesMedPlus Health Services Limited3.39413627277259.2052
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited3.27991011921250.4859
Domestic EquitiesAjanta Pharma Limited3.1227959323238.4829
Domestic EquitiesGland Pharma Limited3.10961529352237.4778
Domestic EquitiesNarayana Hrudayalaya Limited2.83951501224216.8518
Domestic EquitiesAurobindo Pharma Limited2.35941702630180.1893
Domestic EquitiesZydus Lifesciences Limited2.29642000632175.3754
Domestic EquitiesJB Chemicals & Pharmaceuticals Limited2.1524999649164.3773
Domestic EquitiesMankind Pharma Limited1.9467649036148.6682
Domestic EquitiesTorrent Pharmaceuticals Limited1.9431503364148.3967
Domestic EquitiesPfizer Limited1.6880318249128.9147
Domestic EquitiesAlkem Laboratories Limited1.6877277412128.8912
Domestic EquitiesThyrocare Technologies Limited1.58981765838121.4102
Domestic EquitiesSanofi India Limited1.5111230272115.4020
Domestic EquitiesIPCA Laboratories Limited1.3939785412106.4508
Domestic EquitiesFortis Healthcare Limited1.32741654582101.3762
Domestic EquitiesSanofi Consumer Healthcare India Limited1.273621365997.2661
Domestic EquitiesSai Life Sciences Limited1.2201135058493.1768
Domestic EquitiesSuraksha Diagnostic Limited1.0911316961883.3293
Domestic EquitiesSyngene International Limited0.9609112479573.3816
Domestic EquitiesBiocon Limited0.9046228422269.0863
Domestic EquitiesDr. Lal Path Labs Limited0.874728911266.7979
Domestic EquitiesOrchid Pharma Limited0.620149272747.3535
Domestic EquitiesAstraZeneca Pharma India Limited0.56206407842.9236
Domestic EquitiesIndoco Remedies Limited0.4721183492436.0508
Domestic EquitiesEmcure Pharmaceuticals Limited0.385630000029.4510
Domestic EquitiesKrishna Institute Of Medical Sciences Limited0.315146178524.0613
Domestic EquitiesConcord Biotech Limited0.218911173816.7171
Total 98.8878 7552.0976
Cash & Cash Equivalents and Net AssetsTriparty Repo1.3182 100.6687
Cash & Cash Equivalents and Net AssetsCash Margin - CCIL0.0072 0.5519
Cash & Cash Equivalents and Net AssetsNet Current Assets-0.2132 -16.2801
Total 1.1122 84.9405
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.